Researchers evaluated the humoral and cellular immune responses to pertussis vaccination in COPD patients.
Researchers identify biomarkers for checkpoint inhibitor-induced hyperprogression of melanoma cells
Duke Cancer Institute researchers have identified potential biomarkers that predict the likelihood for checkpoint inhibitor drugs to backfire, driving hyper-progression of melanoma cells instead of